SEI Investments’s Five Prime Therapeutics, Inc. FPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-33,856
| Closed | -$576K | – | 2686 |
|
|
2021
Q1 | $576K | Hold |
33,856
| – | – | ﹤0.01% | 1964 |
|
|
2020
Q4 | $576K | Buy |
+33,856
| New | +$424K | ﹤0.01% | 1917 |
|
|
2018
Q3 | – | Sell |
-3
| Closed | – | – | 3661 |
|
|
2018
Q2 | $0 | Sell |
3
-11
| -79% | -$192 | ﹤0.01% | 3881 |
|
|
2018
Q1 | $0 | Buy |
14
+3
| +27% | +$59 | ﹤0.01% | 3754 |
|
|
2017
Q4 | $0 | Sell |
11
-5
| -31% | -$161 | ﹤0.01% | 3572 |
|
|
2017
Q3 | $1K | Hold |
16
| – | – | ﹤0.01% | 3145 |
|
|
2017
Q2 | $0 | Buy |
16
+15
| +1,500% | +$468 | ﹤0.01% | 3364 |
|
|
2017
Q1 | $0 | Sell |
1
-57
| -98% | -$2.51K | ﹤0.01% | 3137 |
|
|
2016
Q4 | $3K | Sell |
58
-1,301
| -96% | -$68.4K | ﹤0.01% | 2697 |
|
|
2016
Q3 | $71K | Buy |
1,359
+444
| +49% | +$21.2K | ﹤0.01% | 1967 |
|
|
2016
Q2 | $38K | Buy |
915
+689
| +305% | +$30K | ﹤0.01% | 2015 |
|
|
2016
Q1 | $9K | Buy |
+226
| New | +$7.77K | ﹤0.01% | 2209 |
|
SEI Investments's FPRX Position: Q2 2021 in Review
SEI Investments sold out of Five Prime Therapeutics, Inc. (FPRX) in Q2 2021, closing a stake of 33,856 shares — an estimated $576K sold.
SEI Investments first reported a position in FPRX in Q1 2016 and held it in 12 quarters. The position peaked at $576K in Q1 2021. 0 funds tracked by Wall St. Rank hold FPRX as of Q2 2021.
- SEI Investments reported no remaining Five Prime Therapeutics, Inc. position as of Q2 2021 after selling out during the quarter.
- SEI Investments sold 33,856 Five Prime Therapeutics, Inc. shares in Q2 2021, an estimated $576K.
- SEI Investments first reported a position in Five Prime Therapeutics, Inc. in Q1 2016 and held it in 12 quarters.
- SEI Investments's Five Prime Therapeutics, Inc. position peaked at $576K in Q1 2021.
- 0 funds tracked by Wall St. Rank held Five Prime Therapeutics, Inc. as of Q2 2021.
Based on SEI Investments's 13F filing for Q2 2021, filed 6 Aug 2021.